Refractory Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB01229Paclitaxel1Recruiting1
DB11771Tremelimumab1 / 2Recruiting1
DB08916Afatinib2Completed1